Diabetes News and Research

Latest Diabetes News and Research

New potential anti-tumor agents might effectively treat mesothelioma

Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors.

26 Jul 2011

Symposium on early childhood dental disease

Leaders in medicine and dentistry will meet in Seattle July 28-29 to discuss a new approach in the fight against childhood dental disease: enlisting family physicians and pediatricians.

26 Jul 2011

Foot care tips for diabetes patients

With the peak of summer now upon us, many of us will take time to kick off the shoes and take a walk on the beach or maybe on a grassy field in the local park. Some may even hop into a river or creek to cool off. No worries, right? Well, for some people, relaxing barefoot comes with some concern. Specifically, those with diabetes need to pay close attention to their feet.

26 Jul 2011

UC San Diego receives NHLBI 'Program of Excellence in Glycosciences' grant

Scientists at the University of California, San Diego School of Medicine have received a major 7-year, $18 million grant to begin translating emerging discoveries in the field of glycosciences into new discoveries and therapies related to heart, lung and blood diseases.

26 Jul 2011

Type 2 diabetes and obesity in pregnancy is a daunting duo: New research

Type 2 diabetes and obesity in pregnancy is a daunting duo, according to new research published this month in The Journal of Maternal-Fetal and Neonatal Medicine. The study shows that both conditions independently contribute to higher risks, opening the door to a wide range of pregnancy, delivery and newborn complications.

26 Jul 2011

Women & Infants creates fully integrated center for high-risk pregnancy

Every pregnancy deserves special treatment. But when a woman with a normal pregnancy has a complication or a woman with a medical issue becomes pregnant, she needs highly specialized care.

26 Jul 2011

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA

Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc., resubmitted two New Drug Applications to the United States Food and Drug Administration for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.

26 Jul 2011

Diabetes drug rosiglitazone can reduce development of neuropathic pain

The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve damage and abnormal pain responses, suggests a paper in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

26 Jul 2011

When psoriasis strikes the famously beautiful

It appears that psoriasis spares none. Reality TV star Kim Kardashian has been reportedly diagnosed with the skin condition. Her condition was revealed on a recent episode of “Keeping Up with the Kardashians” on E!.

25 Jul 2011

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

GI Dynamics, Inc., a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of type 2 diabetes and obesity, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the EndoBarrier® Gastrointestinal Liner for inclusion on the Australian Register of Therapeutic Goods (ARTG).

25 Jul 2011

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter International Inc. announced today that the U.S. Food and Drug Administration has approved the subcutaneous administration of GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] for patients with primary immunodeficiency.

From Baxter International Inc. 25 Jul 2011

Valeritas' V-Go Disposable Insulin Delivery Device receives CE Mark approval

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.

25 Jul 2011

Study: Mail-order pharmacy use linked to improved cardiovascular risk factor outcomes

Kaiser Permanente Northern California patients who obtained new statin prescriptions via a mail-order pharmacy achieved better cholesterol control in the first 3-15 months following the initiation of therapy -- compared to those patients who only obtained their statin prescription from their local Kaiser Permanente Northern California pharmacy.

25 Jul 2011

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its supplemental Biologics License Application (sBLA) for SIMPONI.

25 Jul 2011

C-sections on the rise: One in three mothers opting for procedure

According to the latest study reports, one in three births in the U.S. are now delivered by Caesarean section, which is an all time high and an increasd of 25 percent over seven years.

24 Jul 2011

Rats, fish oil and beetroot juice could lead to health breakthroughs for aging populations

Though rats, fish oil and beetroot juice read like ingredients in a witch's brew, to a Kansas State University research team, information from this combination could lead to health breakthroughs for aging populations and people suffering from heart failure and diabetes.

22 Jul 2011

Homeless people report using street drugs to treat their pain

Chronic pain is not managed well in the general population and it's an even greater challenge for homeless people, according to new research by St. Michael's Hospital.

22 Jul 2011

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

Ronald Reagan UCLA Medical Center ranks among the top five American hospitals, according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors. The medical center also was rated the best hospital in the western United States for the 22nd consecutive year and the No. 1 hospital in the Los Angeles metropolitan area.

22 Jul 2011

Research roundup: Restricting Medigap coverage; Hospital-acquired infections

Increases In Mortality, Length Of Stay, And Cost Associated With Hospital-Acquired Infections In Trauma Patients -- This study explores the clinical and economic burden of hospital-acquired infections, the most common complication in hospitalized patients, for trauma patients.

22 Jul 2011

Metabolic syndrome increases risk of developing HCC and ICC primary liver cancers

Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the U.S. This population-based study publishing in the August issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, found that metabolic syndrome significantly increases risk of developing these primary liver cancers.

22 Jul 2011